The Flavin-Containing Monooxygenase 3 Gene and Essential Hypertension: The Joint Effect of Polymorphism E158K and Cigarette Smoking on Disease Susceptibility

International Journal of Hypertension

Volumn 2014, Issue , 2014, Pages

  Bushueva, Olga ^a   Solodilova, Maria ^a   Churnosov, Mikhail ^b   Ivanov, Vladimir ^a   Polonikov, Alexey ^a  

^a KURSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^b BELGOROD STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESSENTIAL HYPERTENSION; FEMALE; FLAVIN CONTAINING MONOOXYGENASE 3 GENE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RUSSIAN FEDERATION; SMOKING;

EID: 84934948692     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2014/712169     Document Type: Article

References (15)

1. A. M. Briones and R. M. Touyz, "Oxidative stress and hypertension: current concepts", Current Hypertension Reports, vol. 12, no. 2, pp. 135-142, 2010.
2. N. F. Renna, "Oxidative stress, vascular remodeling, and vascular inflammation in hypertension", International Journal of Hypertension, vol. 2013, Article ID 710136, 2 pages, 2013.
3. S. K. Krueger and D. E. Williams, "Mammalian flavincontaining monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism", Pharmacology and Therapeutics, vol. 106, no. 3, pp. 357-387, 2005.
4. 3 gene: significance for detoxication", Drug Metabolismand Disposition, vol. 28, no. 2, pp. 169-173, 2000.
5. 3 gene in a North American cohort", Molecular Genetics and Metabolism, vol. 68, no. 1, pp. 24-31, 1999.
6. 3) gene do not predispose to essential hypertension in Caucasians", BMC Medical Genetics, vol. 6, article 41, 2005.
7. A. V. Polonikov, V. P. Ivanov, M. A. Solodilova et al., "A common polymorphism G-50T in cytochrome P450 2J2 gene is associated with increased risk of essential hypertension in a Russian population", Disease Markers, vol. 24, no. 2, pp. 119-126, 2008.
8. I. N. Sorokina, M. I. Churnosov, and E. V. Balanovskaia, "The gene pool of the Belgorod region population: description of the "genetic landscape" of 22 district populations", Genetika, vol. 45, no. 5, pp. 700-710, 2009.
9. E. K. Vialykh, M. A. Solodilova, O. Y. Bushueva, I. V. Bulgakova, and A. V. Polonikov, "Catalase gene polymorphismis associated with increased risk of cerebral stroke in hypertensive patients", Zhurnal Nevrologii i Psihiatrii imeni S. S. Korsakova, vol. 112, no. 8, part 2, pp. 3-7, 2012.
10. 3) cause trimethylaminuria, a defect in detoxication", Human Molecular Genetics, vol. 7, no. 5, pp. 839-845, 1998.
11. R. M. Touyz, "Oxidative stress and vascular damage in hypertension", Current Hypertension Reports, vol. 2, no. 1, pp. 98-105, 2000.
12. J. de Champlain, R. Wu, H. Girouard et al., "Oxidative stress in hypertension", Clinical and Experimental Hypertension, vol. 26, no. 7-8, pp. 593-601, 2004.
13. N. D. Vaziri and B. Rodríguez-Iturbe, "Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension", Nature Reviews Nephrology, vol. 2, no. 10, pp. 582-593, 2006.
14. A. Virdis, C. Giannarelli, M. F. Neves, S. Taddei, and L. Ghiadoni, "Cigarette smoking and hypertension", Current Pharmaceutical Design, vol. 16, no. 23, pp. 2518-2525, 2010.
15. M. A. H. Talukder, W. M. Johnson, S. Varadharaj et al., "Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice", The American Journal of Physiology-Heart and Circulatory Physiology, vol. 300, no. 1, pp. H388-H396, 2011.